Artificial Intelligence Predicts Next Session’s Price Change For Ingersoll, AT&T, Visa

(VIANEWS) – Today, the Innrs artificial intelligence algorithm suggests a high probability of discovering the approximate price for tomorrow of Ingersoll IR, AT&T T and others.

Via News will regularly fact-check this AI algorithm that aims to consistently predict the next session price and next week’s trend of financial assets.

Innrs provides A.I.-based statistical tools to help investors make decisions. The table below shows the financial assets predicting price, ordered by the highest expected accuracy.

Innrs officials say this tool helps investors make better-informed decisions, supposedly used alongside other relevant financial information and the specific trader strategy.

In the next session, Via News will report the finding on the algorithm precision.

1. Ingersoll (IR)

Shares of Ingersoll rose by a staggering 18.03% in from $60.19 to $71.04 at 03:21 EST on Tuesday, after five sequential sessions in a row of gains. NYSE is dropping 0.33% to $15,930.89, after two sequential sessions in a row of gains.

Ingersoll Rand Inc. provides various mission-critical air, fluid, energy, specialty vehicle, and medical technologies in the United States, Europe, the Middle East, India, Africa, and the Asia Pacific. It operates through two segments, Industrial Technologies and Services, and Precision and Science Technologies. The Industrial Technologies and Services segment designs, manufactures, markets, and services air and gas compression, vacuum, and blower products; fluid transfer equipment and loading systems; and power tools and lifting equipment, including associated aftermarket parts, consumables, air treatment equipment, controls, other accessories, and services under the under the Ingersoll Rand, Gardner Denver, Nash, CompAir, Elmo Rietschle, Robuschi, Emco Wheaton, and Runtech Systems brands. The Precision and Science Technologies segment designs, manufactures, and markets diaphragm, piston, water-powered, peristaltic, gear, vane, progressive cavity, and syringe pumps; and gas boosters, hydrogen compression systems, automated liquid handling systems, odorant injection systems, controls, software, and other related components and accessories for liquid and gas dosing, transfer, dispensing, compression, sampling, pressure management, and flow control in specialized or critical applications under the Air Dimensions, Albin, ARO, Dosatron, Haskel, LMI, Maximus, Milton Roy, MP, Oberdorfer, Seepex, Thomas, Welch, Williams, YZ, and Zinnser Analytic brand names. This segment's products are used in medical, life sciences, industrial manufacturing, water and waste water, chemical processing, energy, food and beverage, agriculture, and other markets. It sells through an integrated network of direct sales representatives and independent distributors. The company was formerly known as Gardner Denver Holdings, Inc. and changed its name to Ingersoll Rand Inc. in March 2020. Ingersoll Rand Inc. was founded in 1859 and is headquartered in Davidson, North Carolina.

More news about Ingersoll.

2. AT&T (T)

Shares of AT&T jumped 5.69% in from $15.3 to $16.17 at 03:21 EST on Tuesday, following the last session’s upward trend. NYSE is falling 0.33% to $15,930.89, after two sequential sessions in a row of gains.

AT&T Inc. provides telecommunications and technology services worldwide. The company operates through two segments, Communications and Latin America. The Communications segment offers wireless voice and data communications services; and sells handsets, wireless data cards, wireless computing devices, and carrying cases and hands-free devices through its own company-owned stores, agents, and third-party retail stores. It also provides Virtual Private Networks, AT&T Dedicated Internet, Ethernet, data services, security, cloud solutions, outsourcing, and managed and professional services, as well as customer premises equipment for multinational corporations, small and mid-sized businesses, governmental, and wholesale customers. In addition, this segment offers broadband services, including fiber connections and legacy telephony voice communication services to residential customers. This segment markets its communications services and products under the AT&T, Cricket, AT&T PREPAID, and AT&T Fiber brand names. The Latin America segment provides postpaid and prepaid wireless services in Mexico under the AT&T and Unefon brand names, as well as sells smartphones through its owned stores, agents and third-party retail stores. The company was formerly known as SBC Communications Inc. and changed its name to AT&T Inc. in 2005. AT&T Inc. was incorporated in 1983 and is based in Dallas, Texas.

Moving Average

AT&T’s worth is higher than its 50-day moving average of $15.01 and under its 200-day moving average of $16.44.

Yearly Top and Bottom Value

AT&T’s stock is valued at $16.17 at 03:21 EST, way under its 52-week high of $21.53 and way higher than its 52-week low of $13.43.

Sales Growth

AT&T’s sales growth is negative 5.3% for the ongoing quarter and negative 4.7% for the next.

More news about AT&T.

3. Visa (V)

Shares of Visa jumped 9.05% in from $232.6 to $253.65 at 03:21 EST on Tuesday, after five consecutive sessions in a row of gains. NYSE is dropping 0.33% to $15,930.89, after two sequential sessions in a row of gains.

Visa Inc. operates as a payment technology company in the United States and internationally. The company operates VisaNet, a transaction processing network that enables authorization, clearing, and settlement of payment transactions. It also offers credit, debit, and prepaid card products; tap to pay, tokenization, and click to pay services; Visa Direct, a solution that facilitates the delivery of funds to eligible cards, deposit accounts, and digital wallets; Visa B2B Connect, a multilateral business-to-business cross-border payments network; Visa Cross-Border Solution, a cross-border consumer payments solution; and Visa DPS that provides a range of value-added services, including fraud mitigation, dispute management, data analytics, campaign management, a suite of digital solutions, and contact center services. The company also provides acceptance solutions, which include Cybersource that provides modular and value-added services for connecting merchants to payment processing; risk and identity solutions, such as Visa Advanced Authorization, Visa Secure, Visa Risk and Decision Manager, Visa Consumer Authentication Service, and payment-decisioning solutions for fraud prevention; and Visa Consulting and Analytics, a payment consulting advisory services. It provides its services under the Visa, Visa Electron, Interlink, V PAY, and PLUS brand names. The company serves merchants, financial institutions, and government entities. Visa Inc. was founded in 1958 and is headquartered in San Francisco, California.

Revenue Growth

Year-on-year quarterly revenue growth grew by 10.6%, now sitting on 32.65B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Visa’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 1.4% and positive 3.3% for the next.

More news about Visa.

4. Coca-Cola Consolidated (COKE)

Shares of Coca-Cola Consolidated jumped by a staggering 11.91% in from $642.73 to $719.28 at 03:21 EST on Tuesday, following the last session’s downward trend. NASDAQ is dropping 0.07% to $14,241.02, following the last session’s downward trend.

Coca-Cola Consolidated, Inc., together with its subsidiaries, manufactures, markets, and distributes nonalcoholic beverages primarily products of The Coca-Cola Company in the United States. The company offers sparkling beverages, such as sparling beverages; and still beverages, including energy products, as well as noncarbonated beverages comprising bottled water, ready to drink coffee and tea, enhanced water, juices, and sports drinks. It also sells its products to other Coca-Cola bottlers; and post-mix products that are dispensed through equipment, which mixes the fountain syrup with carbonated or still water enabling fountain retailers to sell finished products to consumers in cups or glasses. In addition, the company distributes products for various other beverage brands that include Dr Pepper and Monster Energy. It sells and distributes its products directly to grocery stores, mass merchandise stores, club stores, convenience stores, and drug stores; and restaurants, schools, amusement parks, and recreational facilities, as well as through vending machine outlets. The company was formerly known as Coca-Cola Bottling Co. Consolidated and changed its name to Coca-Cola Consolidated, Inc. in January 2019. Coca-Cola Consolidated, Inc. was incorporated in 1980 and is headquartered in Charlotte, North Carolina.

Moving Average

Coca-Cola Consolidated’s value is higher than its 50-day moving average of $656.24 and way higher than its 200-day moving average of $624.95.

More news about Coca-Cola Consolidated.

5. Abbott Laboratories (ABT)

Shares of Abbott Laboratories jumped by a staggering 10.25% in from $92.79 to $102.30 at 03:21 EST on Tuesday, after four consecutive sessions in a row of gains. NYSE is dropping 0.33% to $15,930.89, after two successive sessions in a row of gains.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Sales Growth

Abbott Laboratories’s sales growth is 0.9% for the current quarter and 10.2% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Abbott Laboratories’s stock is considered to be oversold (<=20).

More news about Abbott Laboratories.

6. Public Service Enterprise Group (PEG)

Shares of Public Service Enterprise Group rose 7.28% in from $60.04 to $64.41 at 03:21 EST on Tuesday, after five consecutive sessions in a row of gains. NYSE is falling 0.33% to $15,930.89, after two consecutive sessions in a row of gains.

Public Service Enterprise Group Incorporated, through its subsidiaries, operates as an energy company primarily in Mid-Atlantic United States. The company operates through PSE&G and PSEG Power. The PSE&G segment transmits electricity; distributes electricity and gas to residential, commercial, and industrial customers, as well as invests in solar generation projects, and energy efficiency and related programs; and offers appliance services and repairs. As of December 31, 2022, it had electric transmission and distribution system of 25,000 circuit miles and 864,000 poles; 55 switching stations with an installed capacity of 39,653 megavolt-amperes (MVA), and 235 substations with an installed capacity of 9,735 MVA; four electric distribution headquarters and five electric sub-headquarters; and 18,000 miles of gas mains, 12 gas distribution headquarters, two sub-headquarters, and one meter shop, as well as 56 natural gas metering and regulating stations. Public Service Enterprise Group Incorporated was incorporated in 1985 and is based in Newark, New Jersey.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 17.2% and positive 5% for the next.

Volatility

Public Service Enterprise Group’s last week, last month’s, and last quarter’s current intraday variation average was 0.56%, 0.50%, and 0.99%.

Public Service Enterprise Group’s highest amplitude of average volatility was 0.56% (last week), 0.96% (last month), and 0.99% (last quarter).

Yearly Top and Bottom Value

Public Service Enterprise Group’s stock is valued at $64.41 at 03:21 EST, under its 52-week high of $65.46 and way higher than its 52-week low of $53.71.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Public Service Enterprise Group’s stock is considered to be oversold (<=20).

More news about Public Service Enterprise Group.

7. Charles River Laboratories (CRL)

Shares of Charles River Laboratories rose by a staggering 17.18% in from $168.31 to $197.22 at 03:21 EST on Tuesday, after four sequential sessions in a row of gains. NYSE is falling 0.33% to $15,930.89, after two sequential sessions in a row of gains.

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Volatility

Charles River Laboratories’s last week, last month’s, and last quarter’s current intraday variation average was 1.10%, 0.70%, and 1.71%.

Charles River Laboratories’s highest amplitude of average volatility was 1.10% (last week), 2.27% (last month), and 1.71% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Charles River Laboratories’s stock is considered to be oversold (<=20).

Moving Average

Charles River Laboratories’s worth is higher than its 50-day moving average of $187.88 and below its 200-day moving average of $201.37.

More news about Charles River Laboratories.

8. Sysco Corporation (SYY)

Shares of Sysco Corporation rose 9.33% in from $65.72 to $71.85 at 03:21 EST on Tuesday, after five sequential sessions in a row of gains. NYSE is sliding 0.33% to $15,930.89, after two successive sessions in a row of gains.

Sysco Corporation, through its subsidiaries, engages in the marketing and distribution of various food and related products to the foodservice or food-away-from-home industry in the United States, Canada, the United Kingdom, France, and internationally. It operates through U.S. Foodservice Operations, International Foodservice Operations, SYGMA, and Other segments. The company distributes frozen food, such as meat, seafood, fully prepared entrées, fruits, vegetables, and desserts; canned and dry food products; fresh meat and seafood products; dairy products; beverages; imported specialties; and fresh produce products. It also supplies various non-food items, including paper products comprising disposable napkins, plates, and cups; tableware consisting of glassware and silverware; cookware, such as pots, pans, and utensils; restaurant and kitchen equipment and supplies; and cleaning supplies. The company serves restaurants, hospitals and nursing facilities, schools and colleges, hotels and motels, industrial caterers, and other foodservice venues. Sysco Corporation was incorporated in 1969 and is headquartered in Houston, Texas.

Yearly Top and Bottom Value

Sysco Corporation’s stock is valued at $71.85 at 03:21 EST, way below its 52-week high of $87.21 and way higher than its 52-week low of $62.24.

Volatility

Sysco Corporation’s last week, last month’s, and last quarter’s current intraday variation average was 0.53%, 0.66%, and 0.98%.

Sysco Corporation’s highest amplitude of average volatility was 0.53% (last week), 1.01% (last month), and 0.98% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 8.7% and 8.9%, respectively.

More news about Sysco Corporation.

9. JP Morgan Chase (JPM)

Shares of JP Morgan Chase jumped by a staggering 10.95% in from $137.74 to $152.82 at 03:21 EST on Tuesday, after two sequential sessions in a row of gains. NYSE is falling 0.33% to $15,930.89, after two sequential sessions in a row of gains.

JPMorgan Chase & Co. operates as a financial services company worldwide. It operates through four segments: Consumer & Community Banking (CCB), Corporate & Investment Bank (CIB), Commercial Banking (CB), and Asset & Wealth Management (AWM). The CCB segment offers deposit, investment and lending products, cash management, and payments and services to consumers and small businesses; mortgage origination and servicing activities; residential mortgages and home equity loans; and credit cards, auto loans, leases, and travel services. The CIB segment provides investment banking products and services, including corporate strategy and structure advisory, and equity and debt markets capital-raising services, as well as loan origination and syndication; payments and cross-border financing; and cash and derivative instruments, risk management solutions, prime brokerage, and research. This segment also offers securities services, including custody, fund accounting and administration, and securities lending products for asset managers, insurance companies, and public and private investment funds. The CB segment provides financial solutions, including lending, payments, investment banking, and asset management to small and midsized companies, local governments, nonprofit clients, and large corporations; and commercial real estate banking services to investors, developers, and owners of multifamily, office, retail, industrial, and affordable housing properties. The AWM segment offers multi-asset investment management solutions in equities, fixed income, alternatives, and money market funds to institutional clients and retail investors; and retirement products and services, brokerage, custody, estate planning, lending, deposits, and investment management products. The company also provides ATM, online and mobile, and telephone banking services. JPMorgan Chase & Co. was founded in 1799 and is headquartered in New York, New York.

More news about JP Morgan Chase.

10. Johnson & Johnson (JNJ)

Shares of Johnson & Johnson jumped 3.41% in from $146.24 to $151.23 at 03:21 EST on Tuesday, following the last session’s upward trend. NYSE is dropping 0.33% to $15,930.89, after two sequential sessions in a row of gains.

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Yearly Top and Bottom Value

Johnson & Johnson’s stock is valued at $151.23 at 03:21 EST, way under its 52-week high of $181.04 and above its 52-week low of $144.95.

More news about Johnson & Johnson.

11. Netflix (NFLX)

Shares of Netflix rose by a staggering 17.24% in from $408.87 to $479.36 at 03:21 EST on Tuesday, after four sequential sessions in a row of gains. NASDAQ is falling 0.07% to $14,241.02, following the last session’s downward trend.

Netflix, Inc. provides entertainment services. It offers TV series, documentaries, feature films, and mobile games across various genres and languages. The company provides members the ability to receive streaming content through a host of internet-connected devices, including TVs, digital video players, television set-top boxes, and mobile devices. The company has approximately 231 million paid members in 190 countries. Netflix, Inc. was incorporated in 1997 and is headquartered in Los Gatos, California.

More news about Netflix.

12. Coca-Cola (KO)

Shares of Coca-Cola jumped 3.95% in from $56.14 to $58.36 at 03:21 EST on Tuesday, after five successive sessions in a row of gains. NYSE is falling 0.33% to $15,930.89, after two successive sessions in a row of gains.

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Revenue Growth

Year-on-year quarterly revenue growth grew by 8%, now sitting on 45.03B for the twelve trailing months.

Moving Average

Coca-Cola’s value is above its 50-day moving average of $55.99 and below its 200-day moving average of $59.86.

More news about Coca-Cola.

13. Zoetis (ZTS)

Shares of Zoetis jumped by a staggering 14.21% in from $157.28 to $179.63 at 03:21 EST on Tuesday, after five sequential sessions in a row of gains. NYSE is dropping 0.33% to $15,930.89, after two successive sessions in a row of gains.

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 14.8% and 6.9%, respectively.

More news about Zoetis.

14. Insulet (PODD)

Shares of Insulet rose by a staggering 40.22% in from $134.08 to $188.01 at 03:21 EST on Tuesday, after four successive sessions in a row of gains. NASDAQ is sliding 0.07% to $14,241.02, following the last session’s downward trend.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

More news about Insulet.

15. Verizon (VZ)

Shares of Verizon jumped 7.73% in from $34.67 to $37.35 at 03:21 EST on Tuesday, after five sequential sessions in a row of gains. NYSE is falling 0.33% to $15,930.89, after two successive sessions in a row of gains.

Verizon Communications Inc., through its subsidiaries, provides communications, technology, information, and entertainment products and services to consumers, businesses, and governmental entities worldwide. It operates in two segments, Verizon Consumer Group (Consumer) and Verizon Business Group (Business). The Consumer segment provides wireless services across the wireless networks in the United States under the Verizon and TracFone brands and through wholesale and other arrangements; and fixed wireless access (FWA) broadband through its wireless networks. It also offers wireline services in the Mid-Atlantic and Northeastern United States, as well as Washington D.C. through its fiber-optic network, Verizon Fios product portfolio, and a copper-based network. The Business segment provides wireless and wireline communications services and products, including data, video, conferencing, corporate networking, security and managed network, local and long-distance voice, network access, and various IoT services and products, as well as FWA broadband through its wireless networks. The company was formerly known as Bell Atlantic Corporation and changed its name to Verizon Communications Inc. in June 2000. Verizon Communications Inc. was incorporated in 1983 and is headquartered in New York, New York.

More news about Verizon.

16. Smith & Nephew (SNN)

Shares of Smith & Nephew jumped by a staggering 16.99% in from $22.01 to $25.75 at 03:21 EST on Tuesday, after four successive sessions in a row of gains. NYSE is falling 0.33% to $15,930.89, after two sequential sessions in a row of gains.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products, including instruments, technologies, and implants to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Smith & Nephew’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth grew by 5.2%, now sitting on 5.35B for the twelve trailing months.

Yearly Top and Bottom Value

Smith & Nephew’s stock is valued at $25.75 at 03:21 EST, way under its 52-week high of $33.09 and way higher than its 52-week low of $21.52.

Moving Average

Smith & Nephew’s worth is above its 50-day moving average of $24.92 and below its 200-day moving average of $28.55.

More news about Smith & Nephew.

17. Marriott International (MAR)

Shares of Marriott International rose 9.69% in from $189.02 to $207.34 at 03:21 EST on Tuesday, following the last session’s downward trend. NASDAQ is dropping 0.07% to $14,241.02, following the last session’s downward trend.

Marriott International, Inc. operates, franchises, and licenses hotel, residential, timeshare, and other lodging properties worldwide. The company operates through U.S. and Canada, and International segments. It operates its properties under the JW Marriott, The Ritz-Carlton, Ritz-Carlton Reserve, W Hotels, The Luxury Collection, St. Regis, EDITION, Bvlgari, Renaissance, Le Méridien, Marriott, Sheraton, Westin, Four Points, Delta Hotels by Marriott, Autograph Collection, Tribute Portfolio, Marriott Hotels, Marriott Executive Apartments, Marriott Vacation Club, Gaylord Hotels, Design Hotels, Courtyard, Residence Inn, Fairfield, SpringHill Suites, TownePlace Suites, Protea Hotels, Aloft Hotels, AC Hotels by Marriott, Element Hotels, and Moxy Hotels brand names. It operates properties under 30 brand names in 138 countries and territories. Marriott International, Inc. was founded in 1927 and is headquartered in Bethesda, Maryland.

Volatility

Marriott International’s last week, last month’s, and last quarter’s current intraday variation average was 0.72%, 0.70%, and 1.18%.

Marriott International’s highest amplitude of average volatility was 0.72% (last week), 1.07% (last month), and 1.18% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Marriott International’s stock is considered to be oversold (<=20).

Sales Growth

Marriott International’s sales growth is 5% for the current quarter and 7.6% for the next.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 7.7% and 10%, respectively.

More news about Marriott International.

18. Medtronic (MDT)

Shares of Medtronic rose by a staggering 13.25% in from $69.75 to $78.99 at 03:21 EST on Tuesday, after two consecutive sessions in a row of gains. NYSE is sliding 0.33% to $15,930.89, after two sequential sessions in a row of gains.

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

More news about Medtronic.

19. T-Mobile (TMUS)

Shares of T-Mobile jumped 5.42% in from $140.82 to $148.45 at 03:21 EST on Tuesday, after five sequential sessions in a row of gains. NASDAQ is dropping 0.07% to $14,241.02, following the last session’s downward trend.

T-Mobile US, Inc., together with its subsidiaries, provides mobile communications services in the United States, Puerto Rico, and the United States Virgin Islands. The company offers voice, messaging, and data services to customers in the postpaid, prepaid, and wholesale and other services. It also provides wireless devices, including smartphones, wearables, tablets, home broadband routers, and other mobile communication devices, as well as wireless devices and accessories; financing through equipment installment plans; leasing through JUMP! On Demand; and High Speed Internet services. In addition, the company offers services, devices, and accessories under the T-Mobile and Metro by T-Mobile brands through its owned and operated retail stores, T-Mobile app and customer care channels, and its websites. It also sells its devices to dealers and other third-party distributors for resale through independent third-party retail outlets and various third-party websites. The company was founded in 1994 and is headquartered in Bellevue, Washington.

Yearly Top and Bottom Value

T-Mobile’s stock is valued at $148.45 at 03:21 EST, under its 52-week high of $153.36 and way above its 52-week low of $124.92.

More news about T-Mobile.

20. Walt Disney (DIS)

Shares of Walt Disney jumped by a staggering 18.06% in from $80.53 to $95.07 at 03:21 EST on Tuesday, after two sequential sessions in a row of gains. NYSE is dropping 0.33% to $15,930.89, after two sequential sessions in a row of gains.

The Walt Disney Company operates as an entertainment company worldwide. It operates through three segments: Entertainment, Sports, and Experiences. The company produces and distributes film and television video streaming content under the ABC Television Network, Disney, Freeform, FX, Fox, National Geographic, and Star brand television channels, as well as ABC television stations and A+E television networks; and produces original content under the ABC Signature, Disney Branded Television, FX Productions, Lucasfilm, Marvel, National Geographic Studios, Pixar, Searchlight Pictures, Twentieth Century Studios, 20th Television, and Walt Disney Pictures banners. It also offers direct-to-consumer streaming services through Disney+, Disney+ Hotstar, Hulu, and Star+; sports-related entertainment services through ESPN, ESPN on ABC, ESPN+ DTC, and Star; sale/licensing of film and episodic content to third-party television and VOD services; theatrical, home entertainment, and music distribution services; DVD and Blu-ray discs, electronic home video licenses, and VOD rental services; staging and licensing of live entertainment events; and post-production services. In addition, the company operates theme parks and resorts comprising Walt Disney World Resort, Disneyland Resort, Disneyland Paris, Hong Kong Disneyland Resort, Shanghai Disney Resort, Disney Cruise Line, Disney Vacation Club, National Geographic Expeditions, and Adventures by Disney, as well as Aulani, a Disney resort and spa in Hawaii. It also licenses its intellectual property to a third party for operations of the Tokyo Disney Resort; licenses trade names, characters, visual, literary, and other IP for use on merchandise, published materials, and games; operates a direct-to-home satellite distribution platform; sells branded merchandise through retail, online, and wholesale businesses; and develops and publishes books, comic books, and magazines. The company was founded in 1923 and is based in Burbank, California.

More news about Walt Disney.

21. Royal Caribbean Cruises (RCL)

Shares of Royal Caribbean Cruises rose by a staggering 25.99% in from $84.79 to $106.83 at 03:21 EST on Tuesday, after two successive sessions in a row of losses. NYSE is dropping 0.33% to $15,930.89, after two sequential sessions in a row of gains.

Royal Caribbean Cruises Ltd. operates as a cruise company worldwide. The company operates cruises under the Royal Caribbean International, Celebrity Cruises, and Silversea Cruises brands, which comprise a range of itineraries. As of February 13, 2023, it operated 64 ships. The company was founded in 1968 and is headquartered in Miami, Florida.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 197.3% and 443.5%, respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Royal Caribbean Cruises’s stock is considered to be overbought (>=80).

Volatility

Royal Caribbean Cruises’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.43%, a positive 1.30%, and a positive 1.80%.

Royal Caribbean Cruises’s highest amplitude of average volatility was 0.51% (last week), 2.14% (last month), and 1.80% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 39%, now sitting on 13.17B for the twelve trailing months.

More news about Royal Caribbean Cruises.

22. Ares Capital (ARCC)

Shares of Ares Capital rose 5.25% in from $18.84 to $19.83 at 03:21 EST on Tuesday, after five consecutive sessions in a row of gains. NASDAQ is falling 0.07% to $14,241.02, following the last session’s downward trend.

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 4.8% and positive 3.5% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Ares Capital’s stock is considered to be oversold (<=20).

Moving Average

Ares Capital’s value is above its 50-day moving average of $19.23 and higher than its 200-day moving average of $18.94.

Revenue Growth

Year-on-year quarterly revenue growth grew by 22%, now sitting on 2.55B for the twelve trailing months.

More news about Ares Capital.

23. MercadoLibre (MELI)

Shares of MercadoLibre jumped by a staggering 29.83% in from $1219.83 to $1,583.70 at 03:21 EST on Tuesday, after four successive sessions in a row of gains. NASDAQ is sliding 0.07% to $14,241.02, following the last session’s downward trend.

MercadoLibre, Inc. operates online commerce platforms in Latin America. It operates Mercado Libre Marketplace, an automated online commerce platform that enables businesses, merchants, and individuals to list merchandise and conduct sales and purchases online; and Mercado Pago FinTech platform, a financial technology solution platform, which facilitates transactions on and off its marketplaces by providing a mechanism that allows its users to send and receive payments online, as well as allows users to transfer money through their websites or on the apps. The company also offers Mercado Fondo that allows users to invest funds deposited in their Mercado Pago accounts; Mercado Credito, which extends loans to certain merchants and consumers; and Mercado Envios logistics solution that enables sellers on its platform to utilize third-party carriers and other logistics service providers, as well as fulfillment and warehousing services for sellers. In addition, it provides Mercado Libre Classifieds, an online classified listing service, where users can list and purchase motor vehicles, real estate, and services; Mercado Libre Ads, an advertising platform, which enables large retailers and brands to promote their products and services on the web; and Mercado Shops, an online storefronts solution that enables users to set-up, manage, and promote their own digital stores. The company was incorporated in 1999 and is headquartered in Montevideo, Uruguay.

Moving Average

MercadoLibre’s worth is way above its 50-day moving average of $1,305.22 and way above its 200-day moving average of $1,258.59.

More news about MercadoLibre.

24. American Express (AXP)

Shares of American Express rose by a staggering 14.72% in from $142.75 to $163.76 at 03:21 EST on Tuesday, after two consecutive sessions in a row of gains. NYSE is falling 0.33% to $15,930.89, after two successive sessions in a row of gains.

American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products and services also comprise merchant acquisition and processing, servicing and settlement, point-of-sale marketing, and information products and services for merchants; and fraud prevention services, as well as the design and operation of customer loyalty programs. It sells its products and services to consumers, small businesses, mid-sized companies, and large corporations through mobile and online applications, third-party vendors and business partners, direct mail, telephone, in-house sales teams, and direct response advertising. American Express Company was founded in 1850 and is headquartered in New York, New York.

Moving Average

American Express’s worth is higher than its 50-day moving average of $152.23 and above its 200-day moving average of $161.69.

Sales Growth

American Express’s sales growth is 3.5% for the present quarter and 11.2% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, American Express’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth grew by 10.7%, now sitting on 54.38B for the twelve trailing months.

More news about American Express.

25. Quidel (QDEL)

Shares of Quidel jumped by a staggering 15.04% in from $59.85 to $68.85 at 03:21 EST on Tuesday, following the last session’s upward trend. NASDAQ is falling 0.07% to $14,241.02, following the last session’s downward trend.

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies and solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.

Yearly Top and Bottom Value

Quidel’s stock is valued at $68.85 at 03:21 EST, way below its 52-week high of $102.00 and way higher than its 52-week low of $57.54.

Moving Average

Quidel’s worth is higher than its 50-day moving average of $67.47 and way below its 200-day moving average of $80.80.

More news about Quidel.

26. IDEXX Laboratories (IDXX)

Shares of IDEXX Laboratories jumped by a staggering 21.37% in from $394.28 to $478.54 at 03:21 EST on Tuesday, following the last session’s downward trend. NASDAQ is dropping 0.07% to $14,241.02, following the last session’s downward trend.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

More news about IDEXX Laboratories.

27. Humana (HUM)

Shares of Humana fell 0.88% in from $516.97 to $512.42 at 03:21 EST on Tuesday, after four sequential sessions in a row of gains. NYSE is dropping 0.33% to $15,930.89, after two sequential sessions in a row of gains.

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of PBM business. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 34.6% and 9.5%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 15.9%, now sitting on 102.35B for the twelve trailing months.

Volatility

Humana’s last week, last month’s, and last quarter’s current intraday variation average was 1.37%, 0.05%, and 1.20%.

Humana’s highest amplitude of average volatility was 1.37% (last week), 1.72% (last month), and 1.20% (last quarter).

Yearly Top and Bottom Value

Humana’s stock is valued at $512.42 at 03:21 EST, below its 52-week high of $558.04 and way higher than its 52-week low of $423.29.

More news about Humana.